{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:59:33Z","timestamp":1781078373751,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Invasive aspergillosis (IA) is a major cause of morbidity and mortality in immunocompromised children. Pediatric data are limited, and treatment guidelines often rely on adult studies. This study aimed to assess clinical characteristics and treatment outcomes of pediatric IA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective cohort study of pediatric patients (0\u201318\u00a0years) diagnosed with IA at a tertiary center in T\u00fcrkiye between 2010 and 2022. Data on demographics, underlying conditions,\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      species, antifungal susceptibility, treatment regimens, and outcomes were analyzed. Survival analysis was performed using Kaplan\u2013Meier curves.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty-five children met criteria for proven (69%) or probable (31%) IA after excluding 22 possible cases. Median age was 8.6\u00a0years; mortality did not differ significantly by age, sex, or underlying condition. Hematologic malignancies were the most common comorbidity (35%).\n                      <jats:italic>Aspergillus fumigatus<\/jats:italic>\n                      was the predominant species (57%), and no antifungal resistance was detected. Classical risk factors; central venous catheter use (53%), neutropenia (51%), and recent chemotherapy (35%) were frequent but showed no association with mortality. Lung involvement was the most common presentation (71%), followed by sinus (31%) and central nervous system involvement (13%). Thirty-day mortality was 11%, 12-week mortality was 20% (11\/55), and overall mortality reached 29%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pediatric IA remains associated with substantial morbidity and mortality, although outcomes in this cohort were more favorable than those reported in many prior pediatric series. No single clinical, microbiological, or radiological factor reliably predicted mortality, underscoring the complexity of risk stratification. Early diagnosis and timely antifungal therapy remain essential, and multicenter prospective studies are needed to optimize treatment approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11046-026-01078-1","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:50:33Z","timestamp":1778662233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the Clinical Characteristics and Survival of Pediatric Patients with Invasive Aspergillosis: A 12-year Retrospective Cohort Study"],"prefix":"10.1007","volume":"191","author":[{"given":"Azer","family":"Karaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Bulent","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubra","family":"Aykac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman Oguz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolunay","family":"G\u00fclmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Ozsurekci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"1","key":"1078_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08314-9","volume":"23","author":"L Calle-Miguel","year":"2023","unstructured":"Calle-Miguel L, Garrido-Colino C, Santiago-Garc\u00eda B, et al. Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections. BMC Infect Dis. 2023;23(1):348.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1078_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03099-w","volume":"12","author":"J Huang","year":"2022","unstructured":"Huang J, Liu C, Zheng X. Clinical features of invasive fungal disease in children with no underlying disease. Sci Rep. 2022;12(1):208.","journal-title":"Sci Rep"},{"issue":"suppl_1","key":"1078_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/jpids\/pix046","volume":"6","author":"ZD Pana","year":"2017","unstructured":"Pana ZD, Roilides E, Warris A, Groll AH, Zaoutis T. Epidemiology of invasive fungal disease in children. J Pediatric Infect Dis Soc. 2017;6(suppl_1):S3\u201311.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"9","key":"1078_CR4","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cmi.2019.05.019","volume":"25","author":"A Warris","year":"2019","unstructured":"Warris A, Lehrnbecher T, Roilides E, Castagnola E, Br\u00fcggemann RJM, Groll AH. ESCMIDECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children. Clin Microbiol Infect. 2019;25(9):1096\u2013113.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1078_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/510592","volume":"44","author":"A Upton","year":"2007","unstructured":"Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis. 2007;44(4):531\u201340.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"1078_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3346\/jkms.2015.30.8.1121","volume":"30","author":"SB Han","year":"2015","unstructured":"Han SB, Kim SK, Bae EY, et al. Clinical features and prognosis of invasive pulmonary aspergillosis in Korean children with hematologic\/oncologic diseases. J Korean Med Sci. 2015;30(8):1121\u20138. https:\/\/doi.org\/10.3346\/jkms.2015.30.8.1121.","journal-title":"J Korean Med Sci"},{"issue":"7","key":"1078_CR7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1185\/03007995.2010.487793","volume":"26","author":"WJ Steinbach","year":"2010","unstructured":"Steinbach WJ. Invasive aspergillosis in pediatric patients. Curr Med Res Opin. 2010;26(7):1779\u201387. https:\/\/doi.org\/10.1185\/03007995.2010.487793.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"1078_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/318483","volume":"32","author":"SJ Lin","year":"2001","unstructured":"Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32(3):358\u201366. https:\/\/doi.org\/10.1086\/318483.","journal-title":"Clin Infect Dis"},{"key":"1078_CR9","doi-asserted-by":"crossref","unstructured":"- Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, vd. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. 2014; 15(8):e327\u2013340.","DOI":"10.1016\/S1470-2045(14)70017-8"},{"issue":"4","key":"1078_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myac014","volume":"60","author":"F Al Dhaheri","year":"2022","unstructured":"Al Dhaheri F, Lee RA, Sharma TS, Nakamura MM, Marty FM. Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: a 12-year single-center experience. Med Mycol. 2022;60(4):myac014.","journal-title":"Med Mycol"},{"key":"1078_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2334-7-28","volume":"7","author":"S Cesaro","year":"2007","unstructured":"Cesaro S, Giacchino M, Locatelli F, et al. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients. BMC Infect Dis. 2007;7:28.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1078_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/myc.12161","volume":"57","author":"A Candoni","year":"2014","unstructured":"Candoni A, Caira M, Cesaro S, et al. Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study. Mycoses. 2014;57(6):342\u201350.","journal-title":"Mycoses"},{"issue":"8","key":"1078_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jof7080604","volume":"7","author":"S Sch\u00f6ning","year":"2021","unstructured":"Sch\u00f6ning S, Bochennek K, Gordon K, Groll AH, Lehrnbecher T. Antifungal combination therapy in children with cancer-A 4-year analysis of real-life data of two major pediatric cancer centers. J Fungi. 2021;7(8):604.","journal-title":"J Fungi"},{"key":"1078_CR14","unstructured":"-Guinea JMJ, Arikan-Akdagli S, Muehlethaler K, Kahlmeter G, Arendrup MC. 2022. EUCAST definitive document E.Def 9.4. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. Available from: http:\/\/www.eucast.org"},{"key":"1078_CR15","unstructured":"-Meletiadis J, Guinea J, Arikan-Akdagli S, Friberg N, Kahlmeter G, the Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European 331 Committee for Antimicrobial Susceptibility Testing (EUCAST). 2022. EUCAST definitive document E.Def 10.2: screening method for the detection of azole and echinocandin resistance in Aspergillus using antifungal containing agar plates, exemplified by A. fumigatus. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Files\/EUCAST_EDef_ 10.2_agar_screening_method_final.pdf12-"},{"issue":"6","key":"1078_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1078_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408\u201315.","journal-title":"N Engl J Med"},{"key":"1078_CR18","doi-asserted-by":"publisher","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","volume":"121","author":"A Burgos","year":"2008","unstructured":"Burgos A, Zaoutis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics. 2008;121:e1286\u201394.","journal-title":"Pediatrics"},{"issue":"9","key":"1078_CR19","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1086\/592255","volume":"47","author":"Y Nivoix","year":"2008","unstructured":"Nivoix Y, Velten M, Letscher-Bru V, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis. 2008;47(9):1176\u201384.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1078_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/23744235.2021.2008486","volume":"54","author":"S \u00d6zen","year":"2022","unstructured":"\u00d6zen S, \u00d6zdemir H, Evren E, et al. The role of galactomannan test results in the diagnosis of pediatric invasive aspergillosis. Infect Dis (Lond). 2022;54(4):269\u201376.","journal-title":"Infect Dis (Lond)"},{"issue":"4","key":"1078_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/(SICI)1096-911X(199804)30:4<233::AID-MPO5>3.0.CO;2-H","volume":"30","author":"RE Harris","year":"1998","unstructured":"Harris RE, Sather HN, Feig SA. High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: the Children\u2019s Cancer Group experience. Med Pediatr Oncol. 1998;30(4):233\u20139.","journal-title":"Med Pediatr Oncol"},{"key":"1078_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/00006454-199308000-00009","volume":"12","author":"S Walmsley","year":"1993","unstructured":"Walmsley S, Devi S, King S, et al. Invasive aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J. 1993;12:673\u201382.","journal-title":"Pediatr Infect Dis J"},{"key":"1078_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jpids\/piu074","volume":"4","author":"RL Wattier","year":"2015","unstructured":"Wattier RL, Dvorak CC, Hoffman JA, et al. A prospective, international cohort study of invasive mold infections in children. J Pediatric Infect Dis Soc. 2015;4:313\u201322.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"7","key":"1078_CR24","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1086\/500934","volume":"42","author":"C Cordonnier","year":"2006","unstructured":"Cordonnier C, Ribaud P, Herbrecht R, et al. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. Clin Infect Dis. 2006;42(7):955\u201363.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1078_CR25","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1086\/652768","volume":"50","author":"JW Baddley","year":"2010","unstructured":"Baddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010;50(12):1559\u201367.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1078_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jof7010028","volume":"7","author":"R Sabino","year":"2021","unstructured":"Sabino R, Gon\u00e7alves P, Martins Melo A, et al. Trends on Aspergillus epidemiology-perspectives from a National Reference Laboratory Surveillance Program. J Fungi. 2021;7(1):28. https:\/\/doi.org\/10.3390\/jof7010028. (Published 2021 Jan 6).","journal-title":"J Fungi"},{"key":"1078_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/323335","volume":"34","author":"S Ascioglu","year":"2002","unstructured":"Ascioglu S, Rex JH, De Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7\u201314.","journal-title":"Clin Infect Dis"},{"key":"1078_CR28","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1086\/423381","volume":"39","author":"J Maertens","year":"2004","unstructured":"Maertens J, Raad I, Petrikkos G, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis. 2004;39:1563\u201371.","journal-title":"Clin Infect Dis"},{"key":"1078_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(13)70076-8","volume":"13","author":"CO Morrissey","year":"2013","unstructured":"Morrissey CO, Chen SC, Sorrell TC, et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a ran- domised controlled trial. Lancet Infect Dis. 2013;13:519\u201328.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"1078_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2022.101276","volume":"32","author":"G Lignieres","year":"2022","unstructured":"Lignieres G, Guitard J, Alby-Laurent F, Rambaud J, Bigot J, Morand K, et al. Antifungal combination therapy for invasive fungal infections in a paediatric oncology and haematology department: A retrospective analysis of practice. J Mycol Med. 2022;32(3):101276.","journal-title":"J Mycol Med"},{"issue":"2","key":"1078_CR31","first-page":"37","volume":"6","author":"N Kazakou","year":"2020","unstructured":"Kazakou N, Vyzantiadis TA, Gambeta A, Vasileiou E, Tsotridou E, Kotsos D, et al. Invasive fungal infections in a pediatric hematology-oncology department: A 16-year retrospective study. Crr Med Mycol. 2020;6(2):37\u201342.","journal-title":"Crr Med Mycol"},{"key":"1078_CR32","doi-asserted-by":"crossref","unstructured":"-Meena JP, Gupta AK, Jana M, Seth R. Combination antifungals as an effective means of salvage in paediatric leukaemia patients with invasive fungal infections. Indian J Med Microbiol. Indian J Med Microbio. 2019;37(1):109\u201312","DOI":"10.4103\/ijmm.IJMM_18_157"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01078-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-026-01078-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01078-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:18:49Z","timestamp":1781075929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-026-01078-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1007\/s11046-026-01078-1","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethical committee of Hacettepe University (GO 23\/245).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"54"}}